Medical News

RSS

HLA-Cw*0602 gene variation detected as a high risk for psoriasis

A specific genetic region that has been increasingly identified as the strongest genetic link to psoriasis has an even more significant role in the chronic skin disease than has been suspected, University of Utah medical researchers show in a new study.

27 Aug 2009

Blood thinner warfarin may have opposite effects in kidney disease patients on dialysis

The blood thinner warfarin can prevent strokes in most individuals with abnormal heart rhythms, but the drug may have the opposite effect in kidney disease patients on dialysis, according to a study appearing in an upcoming issue of the Journal of the American Society Nephrology (JASN). The results suggest that warfarin should be prescribed with caution in patients with kidney failure.

27 Aug 2009

Rutgers University Professor receives $3.5 million MERIT Award from NIH

Rutgers University Professor Dipak Sarkar has received a $3.5 million MERIT Award from the National Institutes of Health (NIH) to continue researching the damaging effects of alcohol on the nervous systems of the unborn.

27 Aug 2009

Health Canada issues marketing approval for NeuroVasx's cPAX Aneurysm Treatment System

NeuroVasx, Inc., a medical device company that develops technologies for the treatment of hemorrhagic and ischemic stroke, announced today that it has received approval to market its cPAX Aneurysm Treatment System in Canada from Health Canada's Therapeutic Products Directorate. In addition to Canadian regulatory approval, the cPAX System also received CE Mark in March 2009.

27 Aug 2009

Mylan Pharmaceuticals markets FDA approved first generic version of Sanofi Aventis' BenzaClin

Mylan Inc. (Nasdaq: MYL) today announced that its subsidiary Mylan Pharmaceuticals Inc. has begun to market 1% Clindamycin and 5% Benzoyl Peroxide Gel based on an agreement with licensing partner Dow Pharmaceutical Sciences, a subsidiary of Valeant Pharmaceuticals International. The preparation is the first generic version of Sanofi Aventis' BenzaClin(R) to be approved by the U.S. Food and Drug Administration (FDA).

27 Aug 2009

DURECT signs agreement with King Pharmaceuticals to supply two excipients for REMOXY

DURECT Corporation (Nasdaq: DRRX) today reported that it has signed an exclusive long term excipient supply agreement with respect to REMOXY(R) with King Pharmaceuticals, Inc. (NYSE: KG). This agreement stipulates the terms and conditions under which DURECT will supply to King, based on DURECT's manufacturing cost plus a specified percentage mark-up, two key excipients used in the manufacture of REMOXY.

27 Aug 2009

Premier’s group buy program helps hospitals to save more than $74 million in 2008

At a time when hospital operating margins are paper thin, the Premier healthcare alliance is helping its members achieve enhanced savings through its hospital group buy program. Members who utilized the program generated savings of more than $74 million in 2008.

27 Aug 2009

Research finds that people with psoriasis are less likely to react to looks of disgust by others

People with psoriasis - an often distressing dermatological condition that causes lesions and red scaly patches on the skin - are less likely to react to looks of disgust by others than people without the condition, new research has found.

From The University of Manchester 27 Aug 2009

Study: Patients may face radioactive risk from imaging tests

"At least four million Americans under age 65 are exposed to high doses of radiation each year from medical imaging tests, according to a new study in The New England Journal of Medicine," The New York Times reports. And about ten percent of those patients "receive very high doses, more than the maximum annual exposure allowed for nuclear power plant employees or anyone else who works with radioactive material." The study was based on a survey of nearly one million patients insured by UnitedHealthcare.

27 Aug 2009

Resonant Medical's multi-anatomy Clarity System to be exhibited at ESTRO, Netherlands

Resonant Medical, an innovator in soft tissue planning, image-guidance and adaptive radiotherapy products, today announced that the Company will be exhibiting the next generation of its multi-anatomy Clarity System at the 10th Biennial Meeting of The European Society of Therapeutic Radiology and Oncologists (ESTRO), being held in Maastricht, Netherlands.

27 Aug 2009

E-18 files for an international patent for its revolutionary self-sheathing medical safety syringe technology

E-18 Corp. (OTCBB:ETEN) today announced that its wholly owned subsidiary SquareOne Medical, Inc., doing business as Protectus Medical Devices ("Protectus Medical Devices"), completed an international patent filing for its revolutionary self-sheathing medical safety syringe technology, opening substantial opportunities abroad.

27 Aug 2009

Canadian Anesthesiologists' Society responds to reports on Michael Jackson's death

The Canadian Anesthesiologists' Society (CAS) represents the only trained physicians providing anesthetic services in Canada. CAS is responding to reports that Michael Jackson was given a fatal combination of drugs, including the powerful anesthetic propofol, prior to his death on June 25.

27 Aug 2009

Cumberland Pharmaceuticals posts $9.8 million revenues for the three months ended June 30, 2009

Cumberland Pharmaceuticals Inc. (Nasdaq: CPIX), a specialty pharmaceutical company focused on the hospital acute care and gastroenterology markets, today announced second quarter 2009 financial results.

27 Aug 2009

FBN features Prescient Medical's CEO

Prescient Medical Inc. announced that CEO Patricia Scheller, appeared on FOX Business Network (FBN) to discuss the company's groundbreaking products and recent achievement of CE Mark approval for their vProtect(TM) Luminal Shield Stent System.

27 Aug 2009

Geron provides additional comments on the recent clinical hold of Spinal Cord Injury IND

Geron Corporation today provided additional comments on the recent clinical hold on its Spinal Cord Injury IND.

27 Aug 2009

The Summer 2009 software platform release of Medeanalytics' healthcare performance management solution deployed

MedeAnalytics, a leading provider of healthcare performance management solutions, announced its summer 2009 software platform release, MedeAnalytics 9, which offers performance-packed features for enhanced collaboration and personalization. Deployed to clients on Aug. 17, the release incorporates client input and reflects the company’s ongoing investment in its analytic platform.

27 Aug 2009

Sunquest Information Systems to co-develop laboratory information system with MGH, Partners HealthCare System

Sunquest Information Systems, Inc., a market leader in laboratory and diagnostic information systems, the Massachusetts General Hospital (MGH), an innovator in medical care, research and teaching, and Partners HealthCare System, an integrated health care delivery system with a tradition of IT excellence, today announced a collaborative agreement to jointly develop the next generation anatomic and clinical pathology based laboratory information system.

27 Aug 2009

MBS/Vox hires two new analysts

MBS/Vox, the research-based consultancy unit of CommonHealth specializing in the linguistic analysis of healthcare communication, today announced two new hires.

27 Aug 2009

Roper Industries to raise funds for general corporate purposes and repayment of borrowings

Roper Industries, Inc. (NYSE: ROP) announced today the pricing of its public offering of $500 million of 6.25% Notes due 2019 (the "Notes"). The offering is expected to close, subject to customary closing conditions, on September 2, 2009.

27 Aug 2009

Contract research organization signs agreement to utilize NewCardio's QTinno(TM) software suite

NewCardio, Inc., (OTC Bulletin Board: NWCI) a cardiac diagnostic and services company, today announced that a top-three contract research organization has signed a Master Services Agreement (MSA) to use NewCardio's QTinno(TM) software suite as its technology in fully automated Thorough QT (TQT) and Phase 1 studies delivered by its centralized ECG core lab.

27 Aug 2009

Medical News

HLA-Cw*0602 gene variation detected as a high risk for psoriasis

Blood thinner warfarin may have opposite effects in kidney disease patients on dialysis

Rutgers University Professor receives $3.5 million MERIT Award from NIH

Health Canada issues marketing approval for NeuroVasx's cPAX Aneurysm Treatment System

Mylan Pharmaceuticals markets FDA approved first generic version of Sanofi Aventis' BenzaClin

DURECT signs agreement with King Pharmaceuticals to supply two excipients for REMOXY

Premier’s group buy program helps hospitals to save more than $74 million in 2008

Research finds that people with psoriasis are less likely to react to looks of disgust by others

Study: Patients may face radioactive risk from imaging tests

Resonant Medical's multi-anatomy Clarity System to be exhibited at ESTRO, Netherlands

E-18 files for an international patent for its revolutionary self-sheathing medical safety syringe technology

Canadian Anesthesiologists' Society responds to reports on Michael Jackson's death

Cumberland Pharmaceuticals posts $9.8 million revenues for the three months ended June 30, 2009

FBN features Prescient Medical's CEO

Geron provides additional comments on the recent clinical hold of Spinal Cord Injury IND

The Summer 2009 software platform release of Medeanalytics' healthcare performance management solution deployed

Sunquest Information Systems to co-develop laboratory information system with MGH, Partners HealthCare System

MBS/Vox hires two new analysts

Roper Industries to raise funds for general corporate purposes and repayment of borrowings

Contract research organization signs agreement to utilize NewCardio's QTinno(TM) software suite

How cohesin mechanics and nanotracker tech are redefining DNA research

Todd Bauman and Chris Povich

Scaling organ‑chip technology for human‑relevant drug discovery

Latest News